Ralph Raymond

Teplizumab: A Disease-Modifying Therapy for Type 1 Diabetes That Preserves β-Cell Function

Kevan C. Herold, Stephen E. Gitelman, Peter A. Gottlieb et al. · Diabetes Care · 2023 · 123 citations · Full text

Medicine, Endocrinology, Pharmacotherapy +17

Safety and efficacy of AMG 714 in patients with type 2 refractory coeliac disease: a phase 2a, randomised, double-blind, placebo-controlled, parallel-group study

Christophe Cellier, Gerd Bouma, Tom van Gils et al. · ˜The œLancet. Gastroenterology & hepatology · 2019 · 100 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +10

Vaccination response to tetanus toxoid and 23-valent pneumococcal vaccines following administration of a single dose of abatacept: a randomized, open-label, parallel group study in healthy subjects

Lee K. Tay, Francisco León, George Vratsanos et al. · Arthritis Research & Therapy · 2007 · 94 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Transitional cell carcinoma of the renal pelvis or ureter: Patterns of failure

Scott C. Cozad, Stephen R. Smalley, Mark S. Austenfeld et al. · Urology · 1995 · 83 citations

Medicine, Oncology, Urology +12

Standardized Mixed-Meal Tolerance and Arginine Stimulation Tests Provide Reproducible and Complementary Measures of β-Cell Function: Results From the Foundation for the National Institutes of Health Biomarkers Consortium Investigative Series

Sudha S. Shankar, Adrian Vella, Ralph Raymond et al. · Diabetes Care · 2016 · 75 citations · Full text

Medicine, Endocrinology, Physiology +17